Mr. Wolterman joined NuVasive’s board in July 2015 and was its lead independent director since May 2020. He has nearly 40 years of experience in healthcare, including as president and CEO of Houston-based Memorial Hermann Health System.
“It is an honor to be appointed NuVasive Board Chair, and I am confident in the Company’s ability to transform spine surgery and advance patient care,” Mr. Wolterman said in a news release.
Mr. Wolterman succeeds Gregory Lucier in the role. Mr. Lucier was NuVasive’s CEO from 2015 to 2018, and he stepped down from the board of directors May 18.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.